All articles tagged with #clopidogrel
Recent research challenges traditional heart attack treatments, suggesting clopidogrel may be safer and more effective than aspirin for long-term use, while beta-blockers could increase the risk of a second heart attack and mortality in women, prompting a reevaluation of treatment guidelines.
A recent meta-analysis suggests that clopidogrel is more effective and safer than aspirin for long-term prevention of repeat heart attacks and strokes in patients with coronary artery disease, challenging current guidelines that favor aspirin.
Recent research suggests that the blood-thinning drug clopidogrel may be more effective than aspirin in preventing heart attacks and strokes in people with coronary artery disease, potentially leading to changes in UK guidelines and a shift away from aspirin as the standard long-term preventive treatment.
Doctors have discovered that clopidogrel is more effective than aspirin in preventing heart attacks and strokes in patients with coronary artery disease, without increasing bleeding risks, potentially leading to a change in global treatment guidelines.
A review suggests that switching from aspirin to the blood thinner clopidogrel can reduce the risk of heart attack, stroke, or death by 14% in patients with coronary heart disease, with similar safety profiles and potential cost benefits, prompting calls for updated treatment recommendations.